This is an old revision of the document!
Kyle Sheldrick
Research
Molnupiravir
A paper authored by Kristian Thorlund, Sheldrick, Gideon Meyerowitz-Katz, Sonal Singh, and Andrew Hill critiqued the MOVe-OUT clinical trial studying molnupiravir.1)
Accusing Paul Marik of Research Fraud
In 2022, Sheldrick accused Paul Marik of fabricating data in a study involving the treatment of sepsis patients with intravenous Vitamin C.
Pushback
- On April 17, Professor Norman Fenton published a strong rebuke of Sheldrick's statistical analysis.2)
1)
March 11, 2022 | Kristian Thorlund et al | American Journal of Tropical Medicine and Hygiene | Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial | doi: 10.4269/ajtmh.21-1339